10% Off
Bepogen1.5%
General Pharmaceuticals Ltd.
৳288.00
Add to cart
Bepotas1.5%
Ophthalmic Solution
By
Best PriceTk /
1
Alternatives
Price
Medicine overview
Indications of Bepotas 1.5%
Bepotas 1.5% is indicated for the treatment of itching associated with signs and symptoms of allergic conjunctivitis.
Theropeutic Class
Ophthalmic Anti-allergic preparations
Pharmacology
Bepotastine is direct H1-receptor antagonist and an inhibitor of the release of histamine from mast cells.
Dosage & Administration of Bepotas 1.5%
The recommended dose is 1 drop into the affected eye(s) twice a day. Safety and effectiveness in children below the age of 2 years have not been established.
Dosage of Bepotas 1.5%
The recommended dose is 1 drop into the affected eye(s) twice a day. Safety and effectiveness in children below the age of 2 years have not been established.
Interaction of Bepotas 1.5%
No drug interactions observed but patients who are sensitive to this product molecule should be used with caution.
Contraindications
Contraindicated in patients with a history of hypersensitivity reactions to Bepotas 1.5% or any of the other ingredients of this product.
Side Effects of Bepotas 1.5%
The most common reported side effect occurring in approximately 25% of subjects was a mild taste following instillation. Other side effects occurring in 2-5% of subjects were eye irritation, headache, and nasopharyngitis.
Pregnancy & Lactation
Pregnancy Category C. There are no adequate and well controlled studies in pregnant women. It should be used during pregnancy only if the potential benefit to the mother justifies the potential risk to the fetus.Lactation: It is not known if Bepotas 1.5% is excreted in human milk. Caution should be exercised when it is administered to a nursing woman.
Precautions & Warnings
To minimize the risk of contamination, do not touch dropper tip to any surface. It should not be used to treat contact lens-related irritation. Patients should be advised not to wear contact lens when using this drop.
Overdose Effects of Bepotas 1.5%
If you use more Bepotas 1.5% eye drops than you should, rinse your eye with warm water. Do not put in any more drops until it is time for your next regular dose. Pharmaceutical Precautions
Storage Conditions
Store in a cool, dry place & protected from light. Keep out of reach of children. Do not use more than 4 weeks after opening.
Drug Classes
Ophthalmic Anti-allergic preparations
Mode Of Action
Bepotastine is direct H1-receptor antagonist and an inhibitor of the release of histamine from mast cells.
Pregnancy
Pregnancy Category C. There are no adequate and well controlled studies in pregnant women. It should be used during pregnancy only if the potential benefit to the mother justifies the potential risk to the fetus.Lactation: It is not known if Bepotas 1.5% is excreted in human milk. Caution should be exercised when it is administered to a nursing woman.
Frequently Asked Questions
What is Bepotas 1.5% used for?
Bepotastine Besilate is indicated for the treatment of itching associated with signs and symptoms of allergic conjunctivitis.
What is the dosage of Bepotas 1.5%?
The recommended dose is 1 drop into the affected eye(s) twice a day. Safety and effectiveness in children below the age of 2 years have not been established.
What are the side effects of Bepotas 1.5%?
The most common reported side effect occurring in approximately 25% of subjects was a mild taste following instillation. Other side effects occurring in 2-5% of subjects were eye irritation, headache, and nasopharyngitis.
Who should not take Bepotas 1.5%?
Contraindicated in patients with a history of hypersensitivity reactions to Bepotastine Besilate or any of the other ingredients of this product.
What precautions should be taken with Bepotas 1.5%?
To minimize the risk of contamination, do not touch dropper tip to any surface. It should not be used to treat contact lens-related irritation. Patients should be advised not to wear contact lens when using this drop.
Is Bepotas 1.5% safe during pregnancy and breastfeeding?
Pregnancy Category C. There are no adequate and well controlled studies in pregnant women. It should be used during pregnancy only if the potential benefit to the mother justifies the potential risk to the fetus.Lactation: It is not known if Bepotastine Besilate is excreted in human milk. Caution should be exercised when it is administered to a nursing woman.
Disclaimer
The information provided is accurate to our best practices, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy. The absence of specific information about a drug should not be seen as an endorsement. We are not responsible for any consequences resulting from this information, so consult a healthcare professional for any concerns or questions.